- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03119792
Salud Integral Colombia
Salud Integral Colombia (SI! Colombia II).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cardiovascular disease (CVD) is a leading cause of mortality worldwide. Negative health behaviors initiated in childhood that persist through adulthood can be risk factors that predict CVD. In Colombia, poor lifestyle factors affecting childhood are very prevalent: 50% live a sedentary lifestyle, 48% have high fat and carbohydrate consumption, 30% are exposed to passive smoking, 14% are overweight or obese, 15.8% have hypercholesteremia, and 5% have hypertension.
Negative health behaviors initiated in childhood that persist through adulthood can be risk factors that predict CVD. In Colombia, poor lifestyle factors affecting childhood are very prevalent: 50% live a sedentary lifestyle, 48% have high fat and carbohydrate consumption, 30% are exposed to passive smoking, 14% are overweight or obese, 15.8% have hypercholesterolemia, and 5% have hypertension. In May 2009, in Bogota, Colombia, was conducted a cluster randomized trial (kindergartens) in 1216 children between 3 and 6 years old, and 928 parents with the aim of evaluate a five months educational intervention to change knowledge, attitudes and habits related to a healthy diet and active lifestyle in preschoolers. The results showed that the intervention was feasible and effective . Finally every 1216 children "cohort Usaquén" received the intervention, performing a follow-up at 18 and 36 months showing that the changes persisted over time
In 2016 the SI! Program will perform a new follow up of this cohort, in children between 9 and 13 years old, and under the assumption that the effects of this intervention have decreased, the researchers plan to evaluate through a randomized control trial the impact of a four months community educational intervention, in the cardiovascular health of these children and in knowledge, attitudes, habits and emotions towards a healthy lifestyle. The study will include children from the Usaquen´s cohort who are contacted and children of a comparable cohort (n = 1200), in order to achieve sustainable changes in the cardiovascular health of children, that impact the burden of disease in their adulthood.
Due to the high rate of migration within the country, given the social and economic difficulties faced by many Colombians, in 2015 the study population was scattered from 1 to 15 localities and from 14 kindergartens to more than 200 public and private schools, mostly in the Usaquen´s locality, with great variability ranging from the facilities, resources, length of the school day, number of children in each classroom, to the training of teachers and their low motivation and availability time to perform any initiative (data obtained from focus groups conducted in schools). For these reasons, it is not feasible to carry out a second educational intervention in schools. However, the investigators believe that a community-based intervention is an excellent choice for tracking this population.
The objective of this project is two-fold. First, it is to assess differences at baseline in healthy lifestyles between children from Usaquen's cohort and a comparable cohort. The study will also assess differences at baseline in cardiovascular health between parents from Usaquen's cohort, and a comparable cohort. Second, it is to assess the impact of a community pedagogical intervention in healthy lifestyles in children nine to thirteen years old.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bogota, Colombia
- Fundación Cardioinfantil Instituto de Cardiología
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children 9-13 years old from the original Usaquen's cohort
- Children 9-13 years old who are not included in the original cohort (comparable cohort)
- Parents of participating children
Exclusion Criteria:
- Participant unable to consent
- Parents of non-participating children
- Siblings of the Original Usaquen cohort's children that do not belong to the original cohort
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Investigational
An education intervention will be implemented for 600 children from the original cohort (300) and comparable cohort (300) over a four month period at community centers.
These sessions will occur twice a month on the weekends.
The education intervention will help increase the children's knowledge of attitudes, and habits of healthy lifestyles.
|
The education intervention will help increase the children's knowledge of attitudes, and habits of healthy lifestyles.
The program will cover self care of the body and heart, emotional management, healthy diet, and physical activity.
|
|
Active Comparator: Control
The control group will consist of 600 children from the original cohort (300) and comparable cohort (300).
The control group will meet twice a month for four months at community centers.
During these sessions, investigators will teach a curriculum that is not related to knowledge, attitudes, and habits towards healthy lifestyles.
|
The control will not receive an education program relating to knowledge, attitudes, nor habits of healthy lifestyles.
Instead, these sessions will occur twice a month, and will last an hour and forty-five minutes.
The control program is titled "Life's Challenges", which will focus on helping children develop skills necessary for day to day life, is divided into four modules: Person, Family, School, and Environment.
There will be four different types of activities used throughout the program including: "Lets Think," "Lets Experiment," "We will finish with...or synthesis," and "Not here."
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Ideal Cardiovascular Health Score (ICH)
Time Frame: Baseline and 6 months
|
Using the metrics and criteria for individual ideal health factors and behaviors, the ideal cardiovascular health score (ICH) will be calculated for each metric (poor=0, intermediate=1, ideal=2 points; range=0-14 points for all seven metrics) and categorized them into three groups: poor (0-4 points), intermediate (5-9 points), and ideal (10-14 points).
Higher values represent a better outcome.
|
Baseline and 6 months
|
|
Change in KAH score in Children of the Original and Comparable Cohort
Time Frame: Baseline and 6 months
|
Mean and standard deviation of the score of knowledge, attitudes, habits and emotions towards a healthy lifestyle in children will be determined, calculating the difference found between the baseline measurement and the measurement at the end of the study in intervened and control groups in the Original and comparable cohort.
Possible differences between changes in means will be assessed using test t-test.
Multi-variable models will be performed to adjust for potential con-founders.
|
Baseline and 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in ICH score in Children of the Original and Comparable Cohort
Time Frame: Baseline and 6 months
|
Mean difference in scores and standard deviations in cardiovascular health (ICH) at the end of the study between intervened children in the Usaquen´s cohort and intervened children in the comparable cohort, will be determined, using a t-test.
Multivariable models will be performed to adjust for potential confounders.
The prevalence (CI 95%) of each of the 7 components of cardiovascular health rated as poor (risk factor) will be determined, calculating the difference found between the baseline measurement and the measurement at the end of the study in intervened children in the Usaquen´s cohort and intervened children in the comparable cohort.
Possible differences between changes in prevalences will be evaluated using the chi-squared test.
|
Baseline and 6 months
|
|
Change in KAH score in Children of the Usaquen Cohort and Comparable Cohort
Time Frame: Baseline and 6 months
|
Mean and standard deviation of the score of knowledge, attitudes, habits and emotions towards a healthy lifestyle will be determined, calculating the difference found between the baseline measurement and the measurement at the end of the study in intervened children in the Usaquen´s cohort and intervened children in the comparable cohort.
Multivariable models will be performed to adjust for potential confounders.
Possible differences between changes in means will be assessed using a t-test.
|
Baseline and 6 months
|
|
Change in ICH score in Parents of the Original and Comparable Cohort
Time Frame: Baseline and 6 months
|
In parents, mean difference in scores and standard deviations in cardiovascular health (ICH) at the end of the study between intervened and control groups will be determined, using a t-test, differentiating between parents in the Usaquén´s cohort and a comparable cohort.
Multivariable models will be performed to adjust for potential confounders.
The prevalence (CI 95%) of each of the 7 components of cardiovascular health rated as poor (risk factor) will be determined, calculating the difference found between the baseline measurement and the measurement at the end of the study in intervened and control groups differentiating between parents in the Usaquén´s cohort and a comparable cohort.
Possible differences between changes in prevalences will be evaluated using the chi-square test.
|
Baseline and 6 months
|
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: Jorge Baxter, PhD, Mobilizarte Social
- Study Director: Jaime Cespedes, MD, Fundación CardioInfantil de Cardiologia
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- GCO 16-1354
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Health
-
BIO-CAT Microbials, LLCBiofortis Clinical Research, Inc.CompletedImmune Health | Cardiovascular Health | Gastrointestinal Health | Digestive HealthUnited States
-
Lokman Hekim UniversityNot yet recruitingCardiovascular Risk Factors | Health Literacy | Cardiovascular HealthTurkey (Türkiye)
-
UMC UtrechtCompletedCardiovascular Health | Metabolic Health | Pulmonary HealthNetherlands
-
University of Texas Southwestern Medical CenterNot yet recruitingHealth Curiosity | Cardiovascular Health Risk Communication
-
Universidad Metropolitana de Ciencias de la EducacionNot yet recruitingMental Health | Physical Inactivity | Cardiovascular Health | Mental Health Care | Sedentary BehaviorsChile
-
National Yang Ming Chiao Tung UniversityNational Cheng-Kung University HospitalRecruitingMental Health | Lifestyle Intervention | Cardiovascular Health | Physical PerformanceTaiwan
-
Mayo ClinicCompletedCardiovascular Diseases | Cardiovascular HealthUnited States
-
JHSPH Center for Clinical TrialsNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular HealthUnited States
-
Northwestern UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of Illinois at... and other collaboratorsCompletedCardiovascular HealthUnited States
-
Mayo ClinicActive, not recruitingCardiovascular HealthUnited States
Clinical Trials on Education Intervention
-
Ohio State University Comprehensive Cancer CenterCompletedMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedMalignant Solid Neoplasm | Hematopoietic and Lymphatic System NeoplasmUnited States
-
Fred Hutchinson Cancer CenterPrevent Cancer FoundationCompleted
-
M.D. Anderson Cancer CenterWithdrawnStage IB3 Cervical Cancer FIGO 2018 | Stage II Cervical Cancer FIGO 2018 | Stage IIA Cervical Cancer FIGO 2018 | Stage IIA1 Cervical Cancer FIGO 2018 | Stage IIA2 Cervical Cancer FIGO 2018 | Stage IIB Cervical Cancer FIGO 2018 | Stage III Cervical Cancer FIGO 2018 | Stage IIIA Cervical Cancer FIGO... and other conditions
-
Roswell Park Cancer InstituteCompleted
-
University of WashingtonNational Cancer Institute (NCI)CompletedAdvanced Malignant NeoplasmUnited States
-
Mayo ClinicTerminated
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedMalignant NeoplasmUnited States
-
Ohio State University Comprehensive Cancer CenterCompleted
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnCancer Survivor | Peripheral Sensory Neuropathy